Mark Trust

Mark Trust is a seasoned regulatory affairs professional with extensive experience in leading teams and strategies for market expansion and post-approval activities. Currently serving as Senior Director and Head of Post Approval and Market Expansion at Amicus Therapeutics, Mark has previously held prominent roles at AstraZeneca, including Director of Global Regulatory Affairs for the Cardiovascular, Renal, and Metabolic Therapeutic Area, where Mark led cross-functional teams in health authority interactions. Mark also worked as Director of Emerging Markets Regulatory Affairs at AstraZeneca and served as Associate Director Regulatory Affairs Asia Regional Lead at Gilead Sciences, developing regulatory strategies for new drug applications and lifecycle management. Earlier career roles include Director at EMerge Regulatory Solutions, Senior Regulatory Consultant at PAREXEL, and Associate Director of Emerging Markets Regulatory Affairs at Pfizer, alongside initial experience at Abbott Laboratories as a UK Regulatory Compliance Officer and Analytical Development Scientist. Mark holds a Bachelor of Science degree in Biomedical Chemistry from Sheffield Hallam University.